HBM Healthcare Investments
Update in progressHBMN.SW (Swiss)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorFinancial Services
- IndustryAsset Management
HBM Healthcare Investments AG manages funds of funds and direct investments in middle-market and mature companies, with a focus on healthcare—human medicine, pharma, biopharma, biotech, diagnostics, medical technology, and related sectors. It may invest across seed to buyouts, including public companies tied to its private portfolio, via equity, convertibles, debt, or structured products. Follow-ons, majority stakes, board seats, and exits by trade sale or IPO are typical. Global reach, especially Asia-Pacific, North America, and Europe.
Company score
- Sentiment
- 0.48
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- 0.08
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.25
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!